March 1, 2025 – Gelomics is pleased to announce a new strategic partnership with BIOKÉ, a business unit within Cell Signaling Technology Europe B.V. since 2009, a leading provider of innovative life science solutions. Under this agreement, BIOKÉ will serve as Gelomics’ exclusive distributor in the Benelux region, including Belgium, the Netherlands, and Luxembourg.

This partnership strengthens Gelomics’ commitment to providing researchers in the Benelux region with cutting-edge 3D cell culture technologies. With BIOKÉ’s extensive expertise, strong market presence, and dedication to supporting life science research, we are confident that this collaboration will accelerate biomedical innovation and empower scientists to achieve drug development and biomedical research breakthroughs.

“We are excited to partner with BIOKÉ as our exclusive distributor in the Benelux region. Their deep understanding of the life sciences industry and commitment to delivering high-quality solutions align perfectly with our mission to provide ethical, predictive, and cost-effective 3D cell culture technologies. Together, we look forward to advancing biomedical research and enabling scientists to make transformative discoveries.”

– Dr. Christoph Meinert, CEO of Gelomics

“We look forward to offering our customers in the Benelux with revolutionary 3D cell culture technologies from Gelomics. Compared to traditional 2D cultures, which grow cells in flat monolayers with limited spatial context, 3D cultures more closely mimic the physiological conditions of human tissues. This enhanced physiological relevance bridges the gap between in vitro studies and human biology, improving the predictive value of the preclinical research of our customers.”

– Koos Kranenborg, General Manager Europe, BIOKÉ

About Gelomics: Gelomics is revolutionizing drug development and biomedical research by providing advanced 3D cell culture solutions that enable the cultivation of human tissues in vitro. Our mission is to accelerate therapeutic breakthroughs by offering scientists ethical, cost-effective, and predictive alternatives to traditional methods. Learn more at www.gelomics.com.

About BIOKÉ: Founded in 2004, BIOKÉ is a leading provider of innovative life science technologies across Europe. With a knowledgeable and experienced team, the company delivers unique, best-in-class reagents, consumables, and instruments for applications including Next-Generation Sequencing (NGS), cloning, PCR, single-cell research, protein and cellular analysis, and RNA technologies. For more information, visit www.bioke.com.